Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe (Englisch)
- Neue Suche nach: Toussi, Massoud
- Neue Suche nach: Shlaen, Margarita
- Neue Suche nach: Coste, Florence
- Neue Suche nach: de Voogd, Hanka
- Neue Suche nach: Dimos, Vasilis
- Neue Suche nach: Kaplan, Sigal
- Neue Suche nach: Toussi, Massoud
- Neue Suche nach: Shlaen, Margarita
- Neue Suche nach: Coste, Florence
- Neue Suche nach: de Voogd, Hanka
- Neue Suche nach: Dimos, Vasilis
- Neue Suche nach: Kaplan, Sigal
In:
Pharmacoepidemiology and Drug Safety
;
30
, 3
;
292-303
;
2021
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe
-
Beteiligte:Toussi, Massoud ( Autor:in ) / Shlaen, Margarita ( Autor:in ) / Coste, Florence ( Autor:in ) / de Voogd, Hanka ( Autor:in ) / Dimos, Vasilis ( Autor:in ) / Kaplan, Sigal ( Autor:in )
-
Erschienen in:Pharmacoepidemiology and Drug Safety ; 30, 3 ; 292-303
-
Verlag:
- Neue Suche nach: John Wiley & Sons, Inc.
-
Erscheinungsdatum:01.03.2021
-
Format / Umfang:12 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 30, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 277
-
Measured and accounted‐for confounding in pharmacoepidemiologic studies: Some thoughts for practitionersRoy, Jason / Mitra, Nandita et al. | 2021
- 283
-
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in EuropeToussi, Massoud / Isabelle, Bardoulat / Tcherny‐Lessenot, Stephanie / de Voogd, Hanka / Dimos, Vasilis / Kaplan, Sigal et al. | 2021
- 292
-
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in EuropeToussi, Massoud / Shlaen, Margarita / Coste, Florence / de Voogd, Hanka / Dimos, Vasilis / Kaplan, Sigal et al. | 2021
- 304
-
New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self‐reportsBrüne, Manuela / Andrich, Silke / Haastert, Burkhard / Kaltheuner, Matthias / Icks, Andrea et al. | 2021
- 313
-
Confirming diagnoses of acute pancreatitis with commonly available electronic dataNichols, Gregory A. / Déruaz‐Luyet, Anouk / Iliev, Hristo / Brodovicz, Kimberly G. et al. | 2021
- 320
-
Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)Thurin, Nicolas H. / Lassalle, Régis / Schuemie, Martijn / Pénichon, Marine / Gagne, Joshua J. / Rassen, Jeremy A. / Benichou, Jacques / Weill, Alain / Blin, Patrick / Moore, Nicholas et al. | 2021
- 334
-
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?Januskiene, Justina / Segec, Andrej / Slattery, Jim / Genov, Georgy / Plueschke, Kelly / Kurz, Xavier / Arlett, Peter et al. | 2021
- 342
-
Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer RegistryBorges, Fábio C. / Ramos, Catarina / Ramos, Adriana / Mendes, Gonçalo P. / Murteira, Rodrigo / Soares, Patrícia / Furtado, Claudia / Miranda, Ana C. / Costa, Filipa A. / the RON network et al. | 2021
- 350
-
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance dataSegec, Andrej / Slattery, Jim / Morales, Daniel R. / Januskiene, Justina / Kurz, Xavier / Arlett, Peter et al. | 2021
- 360
-
Patterns of opioid use in older people diagnosed with cancer in New South Wales, AustraliaTervonen, Hanna E / Schaffer, Andrea L / Luckett, Tim / Phillips, Jane / Litchfield, Melisa / Todd, Adam / Pearson, Sallie‐Anne et al. | 2021
- 371
-
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indicationGonzález‐Bermejo, Diana / Rayón‐Iglesias, Pilar / Rodríguez‐Pascual, Alfonso / Álvarez‐Gutiérrez, Arturo / Fernández‐Dueñas, Ana / Montero‐Corominas, Dolores / Huerta‐Álvarez, Consuelo et al. | 2021
- 379
-
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomesGomes, Tara / Campbell, Tonya / Tadrous, Mina / Mamdani, Muhammad M. / Paterson, J. Michael / Juurlink, David N. et al. | 2021
- 390
-
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–2017Bykov, Katsiaryna / Patorno, Elisabetta / Franklin, Jessica M. / Vine, Seanna M. / Bateman, Brian T. et al. | 2021
- 395
-
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapyHallvik, Sara E. / Johnston, Kirbee / Geddes, Jonah / Leichtling, Gillian / Korthuis, P. Todd / Hartung, Daniel M. et al. | 2021
- 400
-
Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected dataWebster‐Clark, Michael et al. | 2021
- 402
-
Issue Information| 2021